8-K: Nexalin Technology Secures Additional Capital with Partial Over-Allotment Option Exercise

Nexalin Technology, Inc. announced the closing of a partial exercise of its over-allotment option, generating $312,000 in gross proceeds from the sale of 240,000 common shares at $1.30 per share.

Summary

• Nexalin Technology, Inc. (the Company) reported the closing of a partial exercise of the over-allotment option granted to Maxim Group LLC (the Representative).
• On June 5, 2025, the Representative partially exercised its 45-day option to purchase additional shares.
• The Company closed the offering of 240,000 shares of common stock on June 6, 2025.
• These shares were sold at a price of $1.30 per share, consistent with the original public offering price.
• The transaction resulted in aggregate gross proceeds of $312,000 for the Company, prior to underwriter discounts.
• This partial exercise is part of a larger public offering initially reported on May 6, 2025, which included the sale of 3,850,000 common shares and an option for up to 577,500 additional shares.

Sentiment

Score: 6

Explanation: The partial exercise of the over-allotment option is a positive event as it brings in additional capital, though the fact it was only partially exercised (not fully) slightly tempers the positive sentiment, suggesting demand was not strong enough for the full amount.

Positives

• The company successfully raised an additional $312,000 in gross proceeds through the partial exercise of the over-allotment option, enhancing its capital position.
• The shares were sold at the original public offering price of $1.30 per share, indicating consistent pricing and demand for the stock.

Negatives

• The over-allotment option was only partially exercised (240,000 out of a potential 577,500 shares), suggesting less demand than the full option allowed.

Future Outlook

The document does not provide explicit forward-looking statements or guidance beyond the completion of this specific financing transaction.

Management Comments

• Mark White, Chief Executive Officer, signed the report on behalf of Nexalin Technology, Inc.

Industry Context

This filing is a standard follow-up to an equity offering, common for companies raising capital. It reflects a company's ongoing efforts to strengthen its balance sheet or fund operations, aligning with typical capital market activities for publicly traded entities.

Stakeholder Impact

• Shareholders: The issuance of additional shares could lead to minor dilution for existing shareholders, though it also strengthens the company's cash position.
• Company: The company benefits from increased working capital to fund operations or strategic initiatives.

Key Dates

Recommendation

Keywords

Nexalin Technology, NXL, NXLIW, SEC Filing, Form 8-K, Public Offering, Common Stock, Over-Allotment Option, Capital Raise, Maxim Group LLC, Equity Financing, Shares, Proceeds